Actively Recruiting
Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
Led by Universidade Federal Fluminense · Updated on 2025-04-08
34
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
CONDITIONS
Official Title
Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients using one to three antihypertensive medications
- Regular follow-up at the HUAP Medical Clinic for more than 6 months
- No changes in medication doses in the last 3 months
You will not qualify if you...
- Autoimmune and infectious diseases
- Diabetes
- Chronic kidney disease
- Liver disease
- Cancer
- AIDS
- Pregnancy
- Use of catabolic drugs or antibiotics
- Use of antioxidant vitamin supplements, prebiotics, probiotics, symbiotics
- Habitual intake of royal jelly
- Allergy to cornstarch or bee stings
- Acute myocardial infarction (AMI) and/or stroke (CVA) in the last 6 months
- Hypertension stages 2 or 3
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Denise Mafra
Rio de Janeiro, Brazil, 22260050
Actively Recruiting
Research Team
D
Denise mafra, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here